Not all pregnant women with malaria symptoms seek care from their formal healthcare system.
And if they do seek care, they may be given inappropriate treatment because healthcare providers often fail to adhere to the standard (World Health Organization-WHO) diagnostic and treatment guidelines, according to a study by UK researchers published in this week's PLOS Medicine.
GSK Hoping to Introduce Malaria Vaccine Shortly
British pharmaceutical giant GlaxoSmithKline has signaled its intention of coming out with a malaria vaccine.
Advertisement
The authors (led by Jenny Hill from the Liverpool School of Tropical Medicine) reached these conclusions by reviewing all relevant studies that investigated the factors that affect pregnant women's access to malaria treatment and healthcare provider practices for case management of malaria during pregnancy.
In the 37 included studies (mostly from Africa), the authors found that one-quarter to three-quarters of women reported malaria episodes during pregnancy and more than 85% of the women who reported a malaria episode during pregnancy sought some form of treatment. Barriers to access to WHO-recommended treatment among women included poor knowledge about drug safety, and the use of self-treatment practices such as taking herbal remedies. Among healthcare providers, barriers included reliance on clinical diagnosis of malaria and poor adherence to the treatment policy.
![Monthly Treatment Cuts Malaria Risk]( "Monthly Treatment Cuts Malaria Risk")
A year-round preventive drug treatment reduces malaria risk in young kids, finds study.
Although limited by the sparseness of data and by inconsistencies in study methodologies, these findings highlight the need to develop interventions to improve access to and delivery of quality case management of malaria among pregnant women.
The authors conclude: "A systematic assessment of the extent of substandard case management practices of malaria in pregnant women is required, as well as quality improvement interventions that reach all providers administering antimalarial drugs in the community."
They add: "Pregnant women need access to information on which anti-malarial drugs are safe to use at different stages of pregnancy."
Source: Eurekalert
Monthly Treatment Cuts Malaria Risk
A year-round preventive drug treatment reduces malaria risk in young kids, finds study.
Advertisement
Although limited by the sparseness of data and by inconsistencies in study methodologies, these findings highlight the need to develop interventions to improve access to and delivery of quality case management of malaria among pregnant women.
The authors conclude: "A systematic assessment of the extent of substandard case management practices of malaria in pregnant women is required, as well as quality improvement interventions that reach all providers administering antimalarial drugs in the community."
They add: "Pregnant women need access to information on which anti-malarial drugs are safe to use at different stages of pregnancy."
Source: Eurekalert
Effectiveness of Common Anti-Malarial Drug in Controlling Asthma Highlighted in NUS Study
A new pharmacological discovery by researchers from the National University of Singapore (NUS) means that asthmatic patients may soon have a more effective way to control the condition.
Advertisement
 Spread of Drug-Resistant Malaria Speeds Up in SE AsiaDrug-resistant malaria parasites have now established themselves well in border regions in four Southeast Asian countries, imperiling global efforts to control the disease, experts warn Wednesday. | Advertisement
|
Advertisement
